148 related articles for article (PubMed ID: 3928675)
1. Long term treatment of Graves' hyperthyroidism with sodium ipodate.
Shen DC; Wu SY; Chopra IJ; Huang HW; Shian LR; Bian TY; Jeng CY; Solomon DH
J Clin Endocrinol Metab; 1985 Oct; 61(4):723-7. PubMed ID: 3928675
[TBL] [Abstract][Full Text] [Related]
2. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
Karpman BA; Rapoport B; Filetti S; Fisher DA
J Clin Endocrinol Metab; 1987 Jan; 64(1):119-23. PubMed ID: 3782427
[TBL] [Abstract][Full Text] [Related]
3. Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
Shen DC; Wu SY; Chopra IJ; Shian LR; Florsheim W; Solomon DH
Thyroid; 1991; 1(2):143-6. PubMed ID: 1822359
[TBL] [Abstract][Full Text] [Related]
4. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism.
Wu SY; Chopra IJ; Solomon DH; Johnson DE
J Clin Endocrinol Metab; 1978 Dec; 47(6):1358-62. PubMed ID: 263735
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol.
Sharp B; Reed AW; Tamagra EI; Geffner DL; Hershman JM
J Clin Endocrinol Metab; 1981 Sep; 53(3):622-5. PubMed ID: 6894929
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
Roti E; Robuschi G; Manfredi A; D'Amato L; Gardini E; Salvi M; Montermini M; Barlli AL; Gnudi A; Braverman LE
Clin Endocrinol (Oxf); 1985 Apr; 22(4):489-96. PubMed ID: 3838710
[TBL] [Abstract][Full Text] [Related]
7. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
Martino E; Balzano S; Bartalena L; Loviselli A; Sica V; Petrini L; Grasso L; Piga M; Braverman LE
J Endocrinol Invest; 1991 Nov; 14(10):847-51. PubMed ID: 1687043
[TBL] [Abstract][Full Text] [Related]
9. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
Roti E; Robuschi G; Gardini E; Montermini M; Salvi M; Manfredi A; Gnudi A; Braverman LE
Clin Endocrinol (Oxf); 1988 Mar; 28(3):305-14. PubMed ID: 3168311
[TBL] [Abstract][Full Text] [Related]
11. Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves' disease.
Arteaga E; López JM; Rodríguez JA; Michaud P; López G
Clin Endocrinol (Oxf); 1983 Nov; 19(5):619-27. PubMed ID: 6688973
[TBL] [Abstract][Full Text] [Related]
12. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
13. Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
Tomaski SM; Mahoney EM; Burgess LP; Raines KB; Bornemann M
Laryngoscope; 1997 Aug; 107(8):1066-70. PubMed ID: 9261010
[TBL] [Abstract][Full Text] [Related]
14. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.
Wu SY; Chopra IJ; Solomon DH; Bennett LR
J Clin Endocrinol Metab; 1978 Apr; 46(4):691-7. PubMed ID: 582597
[TBL] [Abstract][Full Text] [Related]
15. Sodium ipodate in the treatment of toxic diffuse goiter. Short-term and long-term effects on thyrotoxicosis.
Kamel N; Uysal AR; Koloğlu S; Erdoğan G; Senel M; Polat H
Endocrinologie; 1988; 26(2):99-105. PubMed ID: 3413443
[TBL] [Abstract][Full Text] [Related]
16. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis.
Chopra IJ; van Herle AJ; Korenman SG; Viosca S; Younai S
J Clin Endocrinol Metab; 1995 Jul; 80(7):2178-80. PubMed ID: 7608275
[TBL] [Abstract][Full Text] [Related]
17. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
18. Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
Robuschi G; Manfredi A; Salvi M; Gardini E; Montermini M; d'Amato L; Borciani E; Negrotti L; Gnudi A; Roti E
J Endocrinol Invest; 1986 Aug; 9(4):287-91. PubMed ID: 3537101
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L
J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
[TBL] [Abstract][Full Text] [Related]
20. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
Takamatsu J; Kuma K; Mozai T
J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
